D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 94 Citations 42,322 437 World Ranking 4967 National Ranking 2819

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Disease

The scientist’s investigation covers issues in Migraine, Anesthesia, Placebo, Randomized controlled trial and Chronic Migraine. His work carried out in the field of Migraine brings together such families of science as Tolerability, Clinical trial, Headaches and Intensive care medicine. He studies Cluster headache, a branch of Anesthesia.

His Placebo research includes themes of Clinical endpoint, Pharmacology and Subgroup analysis. Repeated measures design is closely connected to Adverse effect in his research, which is encompassed under the umbrella topic of Randomized controlled trial. He has included themes like Logistic regression, Discontinuation, Young adult, Standard of care and Severity of illness in his Chronic Migraine study.

His most cited work include:

  • The International Classification of Headache Disorders, 3rd edition (beta version) (5079 citations)
  • New Appendix Criteria Open for a Broader Concept of Chronic Migraine (812 citations)
  • A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. (656 citations)

What are the main themes of his work throughout his whole career to date?

Migraine, Anesthesia, Chronic Migraine, Internal medicine and Placebo are his primary areas of study. His Migraine study incorporates themes from Tolerability, Physical therapy, Clinical trial and Intensive care medicine. His study in Physical therapy is interdisciplinary in nature, drawing from both Alternative medicine and Neurology.

A large part of his Anesthesia studies is devoted to Cluster headache. David W. Dodick interconnects Pediatrics, Family medicine and Topiramate in the investigation of issues within Chronic Migraine. David W. Dodick combines subjects such as Clinical endpoint and Randomized controlled trial with his study of Placebo.

He most often published in these fields:

  • Migraine (51.12%)
  • Anesthesia (30.60%)
  • Chronic Migraine (20.15%)

What were the highlights of his more recent work (between 2018-2021)?

  • Migraine (51.12%)
  • Internal medicine (16.79%)
  • Chronic Migraine (20.15%)

In recent papers he was focusing on the following fields of study:

David W. Dodick spends much of his time researching Migraine, Internal medicine, Chronic Migraine, Placebo and Tolerability. His studies in Migraine integrate themes in fields like Adverse effect, Physical therapy, Clinical trial and Family medicine. David W. Dodick has researched Adverse effect in several fields, including Nausea and Anesthesia.

David W. Dodick focuses mostly in the field of Chronic Migraine, narrowing it down to topics relating to Medication overuse and, in certain cases, Sumatriptan. His studies deal with areas such as Subgroup analysis and Confidence interval as well as Placebo. The concepts of his Tolerability study are interwoven with issues in Second opinion and Pediatrics.

Between 2018 and 2021, his most popular works were:

  • CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications. (61 citations)
  • Tau Positron-Emission Tomography in Former National Football League Players (60 citations)
  • Pathophysiology, prevention, and treatment of medication overuse headache. (44 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Disease

His primary areas of study are Migraine, Internal medicine, Chronic Migraine, Pediatrics and Tolerability. His Migraine research incorporates elements of Placebo, Clinical trial and Physical therapy. In general Internal medicine study, his work on Randomized controlled trial and Allodynia often relates to the realm of Serotonin Antagonists, thereby connecting several areas of interest.

His Pediatrics study combines topics in areas such as Migraine prophylaxis, Early onset and Onset of action. His Tolerability research incorporates themes from Second opinion, Reimbursement and Family medicine. His work on Morphine as part of his general Anesthesia study is frequently connected to Post-Traumatic Headache, thereby bridging the divide between different branches of science.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The International Classification of Headache Disorders, 3rd edition (beta version)

Jes Olesen;André Bes;Robert Kunkel;James W. Lance.
Cephalalgia (2013)

8945 Citations

New Appendix Criteria Open for a Broader Concept of Chronic Migraine

J. Olesen;M -G Bousser;H -C Diener;D. Dodick.
Cephalalgia (2006)

1025 Citations

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

Brian G. Weinshenker;Peter C. O'Brien;Tanya M. Petterson;John H. Noseworthy.
Annals of Neurology (1999)

985 Citations

Narrative review: reversible cerebral vasoconstriction syndromes.

Leonard H. Calabrese;David W. Dodick;Todd J. Schwedt;Aneesh B. Singhal.
Annals of Internal Medicine (2007)

891 Citations

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

HC Diener;DW Dodick;SK Aurora;CC Turkel.
Cephalalgia (2010)

816 Citations

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

David W. Dodick;Catherine C. Turkel;Ronald E. Degryse;Sheena K. Aurora.
Headache (2010)

763 Citations

Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

S.D. Silberstein;S. Holland;F. Freitag;D.W. Dodick.
Neurology (2012)

729 Citations

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

Tony W Ho;Michel D Ferrari;David W Dodick;Vince Galet.
The Lancet (2008)

699 Citations

A self-administered screener for migraine in primary care: The ID Migraine™ validation study

Richard B. Lipton;D. Dodick;R. Sadovsky;K. Kolodner.
Neurology (2003)

551 Citations

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

Stephen D. Silberstein;Richard B. Lipton;David W. Dodick;Frederick G. Freitag.
Headache (2007)

483 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David W. Dodick

Peter J. Goadsby

Peter J. Goadsby

University of California, Los Angeles

Publications: 357

Richard B. Lipton

Richard B. Lipton

Albert Einstein College of Medicine

Publications: 250

Shuu-Jiun Wang

Shuu-Jiun Wang

Taipei Veterans General Hospital

Publications: 172

Hans-Christoph Diener

Hans-Christoph Diener

University of Duisburg-Essen

Publications: 131

Stephen D. Silberstein

Stephen D. Silberstein

Thomas Jefferson University

Publications: 129

Marcelo E. Bigal

Marcelo E. Bigal

Albert Einstein College of Medicine

Publications: 124

Rigmor Jensen

Rigmor Jensen

University of Copenhagen

Publications: 118

Jong-Ling Fuh

Jong-Ling Fuh

Taipei Veterans General Hospital

Publications: 115

Jes Olesen

Jes Olesen

University of Copenhagen

Publications: 105

Timothy J. Steiner

Timothy J. Steiner

Norwegian University of Science and Technology

Publications: 87

Jean Schoenen

Jean Schoenen

University of Liège

Publications: 82

Andreas Straube

Andreas Straube

Ludwig-Maximilians-Universität München

Publications: 79

Tobias Kurth

Tobias Kurth

Charité - University Medicine Berlin

Publications: 77

Rami Burstein

Rami Burstein

Beth Israel Deaconess Medical Center

Publications: 72

Giuseppe Nappi

Giuseppe Nappi

University of Pavia

Publications: 71

Arne May

Arne May

Universität Hamburg

Publications: 68

Trending Scientists

Myron D. Flickner

Myron D. Flickner

IBM (United States)

Magdi S. Mahmoud

Magdi S. Mahmoud

King Fahd University of Petroleum and Minerals

Romuald Houdré

Romuald Houdré

École Polytechnique Fédérale de Lausanne

Vitalie Stavila

Vitalie Stavila

Sandia National Laboratories

Valentino J. Stella

Valentino J. Stella

University of Kansas

H. Daniel Wagner

H. Daniel Wagner

Weizmann Institute of Science

Masahiko Ikeuchi

Masahiko Ikeuchi

University of Tokyo

Guozheng Qin

Guozheng Qin

Chinese Academy of Sciences

Hiroshi Shimizu

Hiroshi Shimizu

Hokkaido University

Philip A. Marsden

Philip A. Marsden

University of Toronto

Terry E. Tullis

Terry E. Tullis

Brown University

Samuel M. Behar

Samuel M. Behar

University of Massachusetts Medical School

Armando E. Giuliano

Armando E. Giuliano

Cedars-Sinai Medical Center

Clive Potter

Clive Potter

Imperial College London

George F. Dreher

George F. Dreher

Indiana University

John C. Crotts

John C. Crotts

College of Charleston

Something went wrong. Please try again later.